Plain-English translation of NCT06564571 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →Researchers are developing an artificial intelligence system to help interpret ultrasound images of the pancreas taken during a special procedure called endoscopic ultrasound. This study will compare what the AI system detects in pancreas images against what experienced doctors see, to determine if the AI can accurately spot abnormalities.
Currently, doctors need extensive training to accurately read these detailed pancreas ultrasound images, and interpretation can vary from person to person. This trial aims to see if artificial intelligence could help reduce errors and make diagnosis faster and more consistent for patients with pancreatic disease.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will have your endoscopic ultrasound procedure as normally planned. During or after your procedure, the research team will compare the abnormalities that your doctor identifies in your pancreas images against what an artificial intelligence system detects in the same images. Your participation is observational — you won't receive any new treatment or medication.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
United States
Orlando Health, Inc.
Enrollment target
~310 participants
Started
January 2024
Primary completion
December 2026
Age range
18 Years – 100 Years
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Shyam Varadarajulu, MD
Orlando Health, Digestive Health Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.